Validation of extracellular water determination by bioelectrical impedance analysis in growth hormone-deficient adults.

What Was Tested

The paper reports a study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over), published as a randomized controlled trial.

The researchers validated the determination of extracellular water (ECW) by the bioelectrical impedance method (BIA), using the RJL manufacturer-supplied equation and the equation of Lukaski in 34 growth hormone-deficient (GHD) patients before and after replacement with recombinant human growth hormone (rhGH), using the bromide-dilution (Br-) method as the reference method.

Who Took Part

PubMed indexes the participants as adults and middle-aged adults, both men and women.

How the Study Was Run

The design is described as randomized, double-blind and placebo-controlled.

Because people in this Exogenous HGH, sermorelin & older GHRPs (why they're passed over) study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

Neither the participants nor the staff measuring them knew who was on Exogenous HGH, sermorelin & older GHRPs (why they're passed over), so expectations could not easily colour the readings.

A placebo (an inactive look-alike) gave the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) group a baseline to be compared against.

What Was Measured

Topics PubMed links to this paper include Body Water, Bromides, Electric Impedance, Extracellular Space, Growth Hormone, Hypopituitarism and Indicator Dilution Techniques.

What This Means in Plain Language

The paper is a randomized, double-blind and placebo-controlled study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over).

The publication is from 1995 (Annals of nutrition & metabolism), a journal based in Switzerland.

More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.